Annette Champion - Concepedia

Author

Annette Champion

University of Florida ORCID

Also Known As

A Champion, A. Champion, A.F. Champion, Annette Champion

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Florida St. Luke's-Roosevelt Hospital Center Florida College Columbia University Abbott Fund

About

Annette Champion is an author at University of Florida specializing in medicine, cardiovascular disease, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Public Health	6	6	982
3	Arts	1	1	17
4	Business	1	1	46
5	Health Sciences	1	1	23

Annette Champion

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Franz H. Messerli, Giuseppe Mancia, C Conti, Annals of Internal Medicine	2006	773
Obesity Paradox in Patients with Hypertension and Coronary Artery Disease Seth Uretsky, Franz H. Messerli, Sripal Bangalore, The American Journal of Medicine ObesityMetabolic SyndromeHypertensionObesity ParadoxHealth Policy	2007	547
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST) R. Kolloch, Udo F. Legler, Annette Champion, European Heart Journal	2007	327
Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study Giuseppe Mancia, Franz H. Messerli, George L. Bakris, Hypertension HypertensionCardiovascular PharmacologyPreventive CardiologyBlood PressureAcute Myocardial Infarction	2007	206
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, Yan Gong, Wilmer W. Nichols, The American Journal of Medicine HypertensionCardiovascular DiseaseHealth PolicyAntihypertensive TherapyInvest Substudy	2010	161
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis Sripal Bangalore, Franz H. Messerli, Stanley S. Franklin, European Heart Journal	2009	103
Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen, American Heart Journal ThrombosisCardiovascular DiseasePrior Myocardial InfarctionCardiovascular PharmacologyTreatment Strategy	2008	54
INVEST revisited: review of findings from the International Verapamil SR–Trandolapril Study Rhonda M. Cooper‐DeHoff, Eileen Handberg, Giuseppe Mancia, Expert Review of Cardiovascular Therapy HypertensionInternational EconomicsElderly PatientsCardiovascular PharmacologyPharmacotherapy	2009	46
Predicting Stroke Risk in Hypertensive Patients With Coronary Artery Disease António Coca, Franz H. Messerli, Athanase Bénétos, Stroke	2007	38
Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST]) Scott J. Denardo, Franz H. Messerli, Efraín Gaxiola, The American Journal of Cardiology Percutaneous Coronary InterventionHypertensionCardiovascular EpidemiologyCardiovascular DiseaseAntihypertensive Therapy	2010	38

Page 1